NCT04441762View on ClinicalTrials.gov

Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

December 30, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Acute Renal Colic
Interventions
DRUG

Intravenous Ketorolac Tromethamine

30 mg ketorolac single dose

DRUG

Intranasal Ketorolac Tromethamine

30 mg ketorolac single dose

Trial Locations (1)

123

Sultan Qaboos University Hospital, Muscat

All Listed Sponsors
lead

Oman Medical Speciality Board

OTHER_GOV

NCT04441762 - Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management. | Biotech Hunter | Biotech Hunter